Kangxun 360 and Haoyaoshi Announce Strategic Partnership to Enhance Diabetes Management Services

On January 15, 2016, Kangxun 360 formally signed a cooperation agreement with Beijing Haoyaoshi Pharmacy Chain Co., Ltd. (hereinafter referred to as “Haoyaoshi”). The two parties jointly established an internet-based health management and online sales platform to provide diabetic patients with more personalized services, including online management, online medication purchases, medicine delivery, and logistics distribution. This strategic partnership between Kangxun 360 and Haoyaoshi achieves resource sharing and business complementarity, paving the way for future win-win cooperation.

Kangxun 360 is a mobile internet platform dedicated to blood glucose management. Patients can manage their blood glucose levels through a mobile app. The Diabetes Assistant app integrates health assessment, personalized health plans, health monitoring, and health consultations. It enables the formulation of reasonable dietary and exercise regimens for patients, facilitates detailed recording of health data, and provides real-time expert consultation and guidance, thereby making out-of-hospital blood glucose control easier for patients.

Haoyaoshi is a national pharmaceutical retail chain enterprise. Haoyaoshi Online Pharmacy is the B2C pharmaceutical e-commerce platform under Jointown Pharmaceutical Group (600998.SH), offering nearly 40,000 types of pharmaceuticals and medical devices. The Haoyaoshi Online Pharmacy was officially launched in 2011. In January 2014, Haoyaoshi pioneered the launch of its WeChat store, becoming the first pharmaceutical retailer in China to enable WeChat Pay. In April 2015, Haoyaoshi obtained the Certificate for Internet Drug Transaction Services (No.: Jing C20140004).